Donglan Yuan

509 total citations
35 papers, 353 citations indexed

About

Donglan Yuan is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Donglan Yuan has authored 35 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Donglan Yuan's work include Cancer-related molecular mechanisms research (11 papers), Circular RNAs in diseases (7 papers) and Retinal Diseases and Treatments (3 papers). Donglan Yuan is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Circular RNAs in diseases (7 papers) and Retinal Diseases and Treatments (3 papers). Donglan Yuan collaborates with scholars based in China and United States. Donglan Yuan's co-authors include Hua Qian, Dongqing Yuan, Qinghuai Liu, Aihua Huang, Junxing Huang, Lixin Zhang, Mei Lin, Hong Yu, Min Sha and Songtao Yuan and has published in prestigious journals such as PLoS ONE, Ophthalmology and Medicine.

In The Last Decade

Donglan Yuan

32 papers receiving 353 citations

Peers

Donglan Yuan

IMMUN

OPHTH

T Kolben Germany

Hongji Yang China

S.F. Yim Hong Kong

Jieping Hu China

Zuojian Hu China

Xingdong Cai China

Ashwini Esnakula United States

Dan Wen China

Adela Cimic United States

B. Alexander Knight United States

T Kolben Germany

Donglan Yuan

98 ×0.6

69 ×0.5

96 ×2.2

IMMUN

80 ×2.0

14 ×0.4

OPHTH

Citations per year, relative to Donglan Yuan Donglan Yuan (= 1×) peers T Kolben

Countries citing papers authored by Donglan Yuan

Since Specialization

Citations

This map shows the geographic impact of Donglan Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglan Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglan Yuan more than expected).

Fields of papers citing papers by Donglan Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglan Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglan Yuan. The network helps show where Donglan Yuan may publish in the future.

Co-authorship network of co-authors of Donglan Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Donglan Yuan. A scholar is included among the top collaborators of Donglan Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglan Yuan. Donglan Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Han, Hua Wang, Weiwei Song, et al.. (2025). Artesunate triggers ferroptosis in ovarian cancer via GP130-mediated IL-6/STAT3/OTUB1/SLC711 axis disruption. Phytomedicine. 148. 157269–157269.

Yuan, Donglan, et al.. (2025). Icariside II induces ferroptosis through the down-regulation of SLC7A11 in ovarian cancer. Journal of Ovarian Research. 18(1). 71–71. 1 indexed citations

Wei, Xi, et al.. (2025). Effect of the Nrf2/HO-1 pathway on aluminum-induced liver injury. Ecotoxicology and Environmental Safety. 301. 118488–118488. 2 indexed citations

Gao, Liang, Donglan Yuan, Aihua Huang, & Hua Qian. (2025). Bioinformatics-based identification of differentially expressed genes in endometrial carcinoma: implications for early diagnosis and prognostic stratification. Frontiers in Genetics. 16. 1631060–1631060.

Xu, Jie, et al.. (2024). SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway. Translational Oncology. 49. 102088–102088.

Yuan, Donglan, Zhiqiang Lu, Xin-Rong Xu, & Wei Liu. (2024). RGD peptide-conjugated polydopamine nanoparticles loaded with doxorubicin for combined chemotherapy and photothermal therapy in thyroid cancer. Discover Oncology. 15(1). 794–794. 3 indexed citations

Liu, Fuxing, Donglan Yuan, Xia Liu, et al.. (2023). A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma. Discover Oncology. 14(1). 96–96. 11 indexed citations

Yuan, Donglan, Ting Guo, Dandan Zhu, et al.. (2022). Exosomal lncRNA ATB Derived from Ovarian Cancer Cells Promotes Angiogenesis via Regulating miR-204-3p/TGF&beta;R2 Axis. Dove Medical Press (Taylor and Francis Group). 28 indexed citations

Li, Haifang, et al.. (2022). The Prevention of Venous Thromboembolism After Gynecological Surgery with Nursing Intervention Based on the G-Caprini Scale. International Journal of Women s Health. Volume 14. 1547–1553. 2 indexed citations

10.

Yuan, Donglan, et al.. (2022). Expression of lncRNA NEAT1 in endometriosis and its biological functions in ectopic endometrial cells as mediated via miR-124-3p. Genes & Genomics. 44(5). 527–537. 9 indexed citations

11.

Yuan, Donglan, et al.. (2021). LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p. Journal of Ovarian Research. 14(1). 109–109. 22 indexed citations

12.

Du, Mengmeng, et al.. (2021). Identification of a novel TP63 mutation causing nonsyndromic cleft lip with or without cleft palate. BMC Medical Genomics. 14(1). 53–53. 4 indexed citations

13.

Guo, Ting, Donglan Yuan, Wei Zhang, et al.. (2021). Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a. Human Cell. 34(2). 579–587. 16 indexed citations

14.

Yuan, Donglan, Hua Qian, Ting Guo, et al.. (2020). <p>LncRNA-ATB Promotes the Tumorigenesis of Ovarian Cancer via Targeting miR-204-3p</p>. OncoTargets and Therapy. Volume 13. 573–583. 14 indexed citations

15.

Hua, Ying, et al.. (2018). A tag SNP in syncytin-2 3-UTR significantly correlates with the risk of severe preeclampsia. Clinica Chimica Acta. 483. 265–270. 13 indexed citations

16.

Yan, Hao, Sijing Li, Ping Zheng, et al.. (2018). Intraoperative ultrasound-assisted enucleation of residual fibroids following laparoscopic myomectomy. Clinica Chimica Acta. 495. 652–655. 5 indexed citations

17.

Zhang, Lixin, Hua Qian, Min Sha, et al.. (2016). Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression. PLoS ONE. 11(10). e0164838–e0164838. 34 indexed citations

18.

Ye, Jun, et al.. (2015). MED12 mutation in patients with hysteromyoma. Oncology Letters. 9(6). 2771–2774. 8 indexed citations

19.

Yuan, Dongqing, Donglan Yuan, Songtao Yuan, & Qinghuai Liu. (2013). The Age-related Maculopathy Susceptibility 2 Polymorphism and Polypoidal Choroidal Vasculopathy in Asian Populations. Ophthalmology. 120(10). 2051–2057. 11 indexed citations

20.

Yuan, Dongqing, Donglan Yuan, & Qinghuai Liu. (2012). Association of the Receptor for Advanced Glycation End Products Gene Polymorphisms with Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis. Ophthalmologica. 227(4). 223–232. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact